Found 0 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis) PHASE1 The purpose of this first in human and proof of concept study is to charact...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Temsirolimus in Myelodysplastic Syndrome (MDS) PHASE2 The goal of this Pilot-study is to evaluate the response of unselected MDS ...
Show More Location
Klinikum Chemnitz Klinik für Innere Medizin III
Learn More & Join Trial
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy, such as clofarabine, work in differe...
Show More Location
Azienda ospedaliera Nuovo ospedale "Torrette"
Learn More & Join Trial
Cordimax China Post Market Surveillance PHASE3 Study purpose: This study is a prospective, randomized, controlled multicen...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck N/A This is an open-label, exploratory, biomarker study of intravenous temsirol...
Show More Location
Multiple Locations
Learn More & Join Trial
Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009) PHASE2 This clinical trial will study the use of ridaforolimus in metastatic breas...
Show More Location
Multiple Locations
Learn More & Join Trial
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma PHASE1 RATIONALE: Sorafenib and everolimus may stop the growth of cancer cells by ...
Show More Location
Holden Comprehensive Cancer Center at University of Iowa
Learn More & Join Trial
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders PHASE2 This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Show More Location
The Children's Hospital at TriStar Centennial
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial